.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
UBS
Merck
Chinese Patent Office
QuintilesIMS
Baxter
Express Scripts
Deloitte
Daiichi Sankyo
Cerilliant

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,880,136

« Back to Dashboard

Summary for Patent: 5,880,136

Title: Sulfonamide fibrinogen receptor antagonists
Abstract:A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.
Inventor(s): Duggan; Mark E. (Narberth, PA), Egbertson; Melissa S. (Ambler, PA), Halczenko; Wasyl (Hatfield, PA), Hartman; George D. (Lansdale, PA), Laswell; William L. (Perkasie, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:
Patent Claim Types:
see list of patent claims
Use;

No matches for this query

International Patent Family for Patent: 5,880,136

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria150454► Subscribe
Australia655436► Subscribe
Australia8478291► Subscribe
Canada2052073► Subscribe
China1038748► Subscribe
China1069971► Subscribe
Cyprus2048► Subscribe
Germany19875054► Subscribe
Germany69125235► Subscribe
Denmark0478363► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
QuintilesIMS
Citi
Cantor Fitzgerald
Daiichi Sankyo
US Army
Johnson and Johnson
AstraZeneca
Federal Trade Commission
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot